Picture of Can B logo

CANB Can B Share Price

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m-33.53%
3m-83.39%
6m-62.98%
1yr-95.93%
Volume Change (%)
10d/3m-40.97%
Price vs... (%)
52w High-96.14%
50d MA-27.01%
200d MA-64.99%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Margin-691.08%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Can B EPS forecast chart

Profile Summary

Can B Corp. is a health and wellness company. The Company is engaged in developing, manufacturing, and selling products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. Its products include oils, creams, moisturizers, isolates, gel caps, spa products, and concentrates and lifestyle products. It develops its own line of proprietary products, as well as seeks synergistic value through acquisitions in the hemp industry. Its Duramed Division provides a sam Pro 2.0 medical device to patients through a doctor program whereby the physician evaluates the patients' needs for medical necessity, and if determined that the device use would be beneficial, writes a prescription for the patient, who signs a rental form, for a 35-day cycle for the unit, that is submitted to Duramed who bills the appropriate insurance company. The Company is also focuses on protecting and commercializing the cannabis patents covering liquid formulations of cannabis.

Directors

Last Annual
December 31st, 2023
Last Interim
March 31st, 2024
Incorporated
October 11th, 2005
Public Since
March 11th, 2011
No. of Shareholders
250
No. of Employees
12
Sector
Food & Drug Retailing
Industry
Consumer Defensives
Exchange
us flag iconPink Sheets on Nasdaq
Shares in Issue
54,584,230

CANB Share Price Performance

Upcoming Events for CANB

Q2 2024 Can B Corp Earnings Release

Q3 2024 Can B Corp Earnings Release

Similar to CANB

Picture of American Green logo

American Green

us flag iconPink Sheets on Nasdaq

Picture of Bit Brother logo

Bit Brother

us flag iconPink Sheets on Nasdaq

Picture of Blue Gem Enterprise logo

Blue Gem Enterprise

us flag iconPink Sheets on Nasdaq

Picture of Blum Holdings logo

Blum Holdings

us flag iconPink Sheets on Nasdaq

Picture of Cbd of Denver logo

Cbd of Denver

us flag iconPink Sheets on Nasdaq

FAQ